Table 3.

Costs of Acute HIV Testing and Treatment Strategies, Incremental to Status Quo – Base Case

Strategy*	Incremental Non- HIV Healthcare Costs† (millions)	Incremental HIV Healthcare Costs†¶ (millions)	Incremental ART Costs† (millions)	Incremental Screening & Testing Costs† (millions)	Total Incremental Costs¥ (millions)
90% Annually, Ab+VL + Symptom-based	$302	$214	$435	$12,304	$13,652
90% Annually, Ab + Symptom-based	$272	$334	$459	$4,868	$6,428
67% Annually, Ab+VL + Symptom-based	$179	$54	$238	$9,589	$10,226
67% Annually, Ab + Symptom-based	$156	$89	$235	$4,294	$4,969
90% Annually, Ab	$200	$477	$459	$560	$2,309

^*Ab = antibody testing, VL = viral load testing.

^†Costs are net present values (3% discount rate) over 20 years.

^¶HIV healthcare costs do not include costs of ART.

^¥Costs are net present values (3% discount rate) over 20 years and include future lifetime costs (those incurred after individuals age out of the model upon turning 65 until death, and those incurred by the population alive in the model at the end of 20-year time horizon until that population dies out). This column does not equal the sum of the other four columns because of the inclusion of future lifetime costs.